{
  "report_rows": [
    {
      "kpi": "Q2 adjusted diluted EPS",
      "prediction": "BEAT",
      "answer": "pred ~$4.34 vs. cons $4.23",
      "confidence": "MEDIUM"
    },
    {
      "kpi": "Q2 MIS revenue",
      "prediction": "BEAT",
      "answer": "pred ~$1.22B vs. cons $1.20B",
      "confidence": "MEDIUM"
    },
    {
      "kpi": "Q2 MA ARR growth",
      "prediction": "IN-LINE",
      "answer": "pred ~8.0% vs. cons 8.0%",
      "confidence": "MEDIUM"
    }
  ],
  "guide_rows": [
    {
      "kpi": "Adjusted diluted EPS",
      "prediction": "BETTER",
      "answer": "guide ~$16.85 midpoint vs. cons $16.71 (FY2026)",
      "confidence": "MEDIUM"
    },
    {
      "kpi": "MIS revenue growth",
      "prediction": "BETTER",
      "answer": "guide ~9.5% vs. cons 9.0% (FY2026)",
      "confidence": "MEDIUM"
    },
    {
      "kpi": "MA ARR growth",
      "prediction": "UNCHANGED",
      "answer": "guide ~8.0% vs. cons 8.0% (FY2026)",
      "confidence": "HIGH"
    }
  ],
  "day1_residual_pct": 2.1,
  "day1_confidence": "MEDIUM",
  "day5_residual_pct": 1.2,
  "day5_path": "STABILIZE",
  "day5_rationale": "A FY2026 EPS guide midpoint of ~$16.85 vs. $16.71 consensus would be positive, but after predicted H1 EPS of ~$8.67 vs. ~$8.56 embedded in consensus, implied H2 EPS is only ~$8.18 vs. ~$8.15, limiting follow-through after the initial beat.",
  "day5_confidence": "MEDIUM"
}